GOZZINI, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 2.367
EU - Europa 1.376
AS - Asia 814
SA - Sud America 88
Continente sconosciuto - Info sul continente non disponibili 51
AF - Africa 19
OC - Oceania 13
Totale 4.728
Nazione #
US - Stati Uniti d'America 2.330
RU - Federazione Russa 486
PL - Polonia 287
CN - Cina 232
IT - Italia 230
SG - Singapore 205
HK - Hong Kong 116
IE - Irlanda 104
VN - Vietnam 104
SE - Svezia 87
BR - Brasile 63
KR - Corea 51
FR - Francia 47
DE - Germania 37
FI - Finlandia 28
GB - Regno Unito 27
CA - Canada 24
JO - Giordania 22
IN - India 21
UA - Ucraina 16
AU - Australia 13
CH - Svizzera 13
JP - Giappone 12
ID - Indonesia 9
AR - Argentina 7
IQ - Iraq 7
ZA - Sudafrica 7
BD - Bangladesh 6
CI - Costa d'Avorio 6
EC - Ecuador 6
MX - Messico 6
TR - Turchia 6
VE - Venezuela 5
CO - Colombia 4
ES - Italia 4
PK - Pakistan 4
IL - Israele 3
NL - Olanda 3
BE - Belgio 2
BJ - Benin 2
NG - Nigeria 2
SA - Arabia Saudita 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
LT - Lituania 1
MM - Myanmar 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
RS - Serbia 1
SC - Seychelles 1
Totale 4.677
Città #
Santa Clara 585
Warsaw 287
Ashburn 284
Fairfield 154
Singapore 149
Chandler 114
Dublin 104
Hong Kong 97
San Jose 89
Woodbridge 88
Beijing 83
Seattle 83
Cambridge 76
Houston 65
Milan 57
Seoul 48
Council Bluffs 44
Wilmington 39
Ann Arbor 35
Buffalo 35
Lawrence 29
Princeton 29
Altamura 28
Rome 27
Hanoi 26
Ho Chi Minh City 25
Paris 24
Los Angeles 23
Florence 22
Shanghai 22
The Dalles 22
Jacksonville 18
Lauterbourg 18
Munich 16
Boston 15
Medford 15
New York 14
Melbourne 13
Bern 12
Tokyo 12
Turin 12
Kent 11
Moscow 11
Mumbai 11
San Diego 11
Boardman 10
Clifton 10
Dong Ket 10
Helsinki 8
Orem 8
Redondo Beach 8
Dallas 7
Dearborn 7
Denver 7
Norwalk 7
Phoenix 7
Abidjan 6
Chicago 6
Jakarta 6
Tianjin 6
Barnet 5
Brooklyn 5
Figino 5
Frankfurt am Main 5
Guangzhou 5
Montreal 5
Renton 5
Toronto 5
Detroit 4
Guayaquil 4
Miano 4
Notre Dame 4
Rio de Janeiro 4
São Paulo 4
Yubileyny 4
Baghdad 3
Cape Town 3
Da Nang 3
Falls Church 3
Haiphong 3
Hillsboro 3
London 3
Malang 3
Nuremberg 3
Portsmouth 3
Pune 3
Shenzhen 3
Tappahannock 3
Tel Aviv 3
Turku 3
Venice 3
Abuja 2
Andover 2
Ankara 2
Araraquara 2
Atlanta 2
Baltimore 2
Barcelona 2
Belleville 2
Bogotá 2
Totale 3.229
Nome #
Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine. 350
Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells 299
Severe hypoxia selects hematopoietic progenitors with stem cell potential from primary Myelodysplastic syndrome bone marrow cell cultures. 264
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features 239
Redistribution of H3K27me3 and acetylated histone H4 upon exposure to azacitidine and decitabine results in de-repression of the AML1/ETO target gene IL3. 231
Mutated ASXL1 and number of somatic mutations as possible indicators of progression to chronic myelomonocytic leukemia of myelodysplastic syndromes with single or multilineage dysplasia 221
Acetylome and phosphoproteome modifications in imatinib resistant chronic myeloid leukaemia cells treated with valproic acid. 207
Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine 207
Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells 207
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO positive leukemia cells 191
Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine. 189
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients. 188
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib 181
SPECIFIC DEGRADATION OF THE AML1-ETO/COREPRESSOR COMPLEX BY A NOVEL ORAL HYDROXAMIC ACID DERIVATIVE 169
MAPKS ARE INVOLVED IN THE SURVIVAL AND DIFFERENTIATION OF A T(8;21) ACUTE MYELOID LEUKEMIA CELL LINE AND ARE MODULATED BY THE HDAC INHIBITOR D1 169
Salarin C inhibits maintenance of hypoxia-selected Chronic Myeloid Leukemia progenitor cells 169
INCUBATION OF MURINE ERYTHROLEUKEMIA CELLS IN SEVERE HYPOXIA INDUCES MASSIVE APOPTOSIS PARALLELED BY AKT AND ERK5 CLEAVAGE 159
Complete remission with brentuximab vedotin in a case of primary cutaneous gamma-delta T-cell lymphoma relapsed after allogeneic stem cell transplantation 159
Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors 156
Butyrates as single drug induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts. 152
HDAC INHIBITORS IN COMBINATION WITH HYPOMETHYLATING AGENTS INDUCE SPECIFIC CHROMATIN MODIFICATION AND TRANSCRIPTIONAL ACTIVATION IN CBF/AML CELLS 150
EPIGENETIC MODIFICATIONS IN A T(8;21) ACUTE MYELOID LEUKEMIA CELL LINE CAUSED BY ADMINISTRATION OF THE HDAC INHIBITOR D1 144
ACETYLATION INDUCED BY BUTYRATES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA CAN LEAD TO DIFFENTIATION 130
Iron overload and iron chelation therapy in patients with myelodysplastic syndrome treated by allogeneic stem-cell transplantation: Report from the working conference on iron chelation of the Gruppo Italiano Trapianto di Midollo 127
Autologous haematopoietic stem cell transplantation affects long-term progression independent of relapse activity in aggressive multiple sclerosis: a comparative matched study 70
Totale 4.728
Categoria #
all - tutte 13.323
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.323


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022136 0 0 0 9 2 6 3 12 2 13 34 55
2022/2023494 41 98 37 33 27 78 69 21 52 2 16 20
2023/2024201 10 17 24 8 15 19 9 58 3 4 19 15
2024/20251.337 44 132 99 193 424 244 3 51 36 47 33 31
2025/20261.277 141 159 48 74 178 54 182 62 104 93 30 152
2026/2027180 27 32 119 2 0 0 0 0 0 0 0 0
Totale 4.728